When did MEREO BIOPHARMA GROUP PL-ADR (MREO) report earnings last quarter?
MEREO BIOPHARMA GROUP PL-ADR (MREO) last reported earnings on 11/10/2025.
MEREO BIOPHARMA GROUP PL-ADR (MREO) Earnings History & Surprises
NASDAQ:MREO • US5894921072
Current stock price
0.386 USD
0 (-0.23%)
At close:
0.389 USD
+0 (+0.78%)
After Hours:
MREO Earnings overview
Past quarterly earnings results for MEREO BIOPHARMA GROUP PL-ADR (MREO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 23, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.01
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Nov 10, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$0.01
- EPS Surprise
- 59.64%
- Revenue Surprise
- -100.00%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.01 | -0.02 | 59.64% | 90.00% | 11.9M | -100.00% | - | |
| Q2 2025 | -0.10 | -0.02 | -499.63% | - | 500K | - | - | |
| Q1 2025 | -0.10 | -0.01 | -1,246.69% | - | 19.063M | -100.00% | - | |
| Q4 2024 | -0.05 | -0.01 | -240.11% | -15,215.56% | - | -100.00% | ||
| Q3 2024 | -0.10 | -0.02 | -459.58% | - | - | - | ||
| Q2 2024 | -0.10 | -0.01 | -877.46% | -39,115.69% | - | -100.00% | ||
| Q1 2024 | - | - | - | - | ||||
| Q4 2023 | 0.00 | - | - | 10M | 37.23M | -73.14% | - | |
| Q2 2023 | 0.00 | - | - | 8.788M | - | - | ||
| Q4 2022 | - | - | - | - | ||||
| Q2 2022 | - | - | - | -100.00% | ||||
| Q4 2021 | -0.06 | - | - | - | - | |||
| Q3 2021 | -0.03 | - | - | - | - | |||
| Q2 2021 | -0.04 | - | - | 50.601M | - | - | ||
| Q1 2021 | -0.03 | - | - | - | - | |||
| Q4 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-481.70%
Max EPS beat (4)
59.64%
Min EPS beat (4)
-1,246.69%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, MREO has beaten EPS estimates in 1 out of 4 releases
In the last 4 quarters, MREO reported -481.7% below the EPS estimates on average.
Related analysis
MEREO BIOPHARMA GROUP PL-ADR / MREO Earnings FAQ
Can you provide information on whether MEREO BIOPHARMA GROUP PL-ADR beat earnings estimates in the last quarter?
MEREO BIOPHARMA GROUP PL-ADR (MREO) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often MEREO BIOPHARMA GROUP PL-ADR beats earnings estimates?
In the last 4 quarters, MEREO BIOPHARMA GROUP PL-ADR (MREO) has beaten EPS estimates in 1 out of 4 releases.